Arrowstreet Capital, Limited Partnership Dbv Technologies S.A. Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$4.71 - $5.92 $243,978 - $306,656
-51,800 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$5.32 - $6.53 $11,299 - $13,869
2,124 Added 4.28%
51,800 $283,000
Q1 2021

May 14, 2021
SELL
$2.75 - $6.57 $4,741 - $11,326
-1,724 Reduced 3.35%
49,676 $265,000
Q4 2020

Feb 12, 2021
BUY
$1.38 - $3.01 $70,932 - $154,714
51,400 New
51,400 $135,000

Others Institutions Holding DBVT

# of Institutions
2
Shares Held
3.2K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $95.8M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email